Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Narrative Review

Vol. 20 No. 2 (2022): New Horizons: Innovation in Medicine

An Avant-garde Approach to Life: Reviewing the Current Applications of 3D Bioprinting

DOI
https://doi.org/10.26443/mjm.v20i2.919
Submitted
July 11, 2021
Published
2022-06-23

Abstract

Introduction: The promise of bioprinting tissue constructs that could potentially serve the same function in the human body as native tissues has taken the world of regenerative medicine by storm. The current review describes system-wide clinical applications of three-dimensional (3D) bioprinting and aims to address ethical and social considerations, while also discussing the scope of this technology in the near future.

Discussion: 3D bioprinting is believed to present new approaches to conventional treatment, offering the advantage of customization and on-time availability. It facilitates simultaneous deposition of appropriate bioinks and biomaterials onto scaffolds which can then be employed to develop tissue fabricates that can potentially mimic native tissues in both structure and functionality. It has been extensively employed to regenerate viable tissue constructs of skin, bone, cartilage, vasculature, myocardial tissue and heart valves, nervous tissue, lung and tracheal tissue, liver, pancreatic, and corneal tissue.

Conclusion: To obviate the current restrictions associated with this technology, it is imperative to understand where we currently stand in terms of current clinical applications of 3D bioprinting. This technology is anticipated to contribute significantly to the fields of tissue engineering and regenerative medicine (TERM), where it can be employed to fabricate functional tissues that can simulate their counterparts in the human body.

Relevance: The increasing disparity between organ demand and supply as well as the shortcomings associated with antiquated approaches to treatment call for utilizing 3D bioprinting to develop viable tissue constructs.

References

  1. Li N, Qiao D, Zhao S, Lin Q, Zhang B, Xie F. 3D printing to innovate biopolymer materials for demanding applications: A review. Materials Today Chemistry. 2021 Jun 1;20:100459. https://doi.org/10.1016/j.mtchem.2021.100459
  2. Roseti L, Parisi V, Petretta M, Cavallo C, Desando G, Bartolotti I, et al. Scaffolds for bone tissue engineering: state of the art and new perspectives. Materials Science and Engineering: C. 2017;78:1246-62. https://doi.org/10.1016/j.msec.2017.05.017
  3. Oklu R, Zhang YS, Yue K, Aleman J, Mollazadeh-Moghaddam K, Bakht SM, et al. 3D Bioprinting for Tissue and Organ Fabrication. 2016. http://hdl.handle.net/1721.1/105262
  4. Zhang X, Zhang Y. Tissue engineering applications of three-dimensional bioprinting. Cell biochemistry and biophysics. 2015;72(3):777-82. https://doi.org/10.1007/s12013-015-0531-x
  5. Heinrich MA, Liu W, Jimenez A, Yang J, Akpek A, Liu X, et al. 3D bioprinting: from benches to translational applications. Small. 2019;15(23):1805510. https://doi.org/10.1002/smll.201805510
  6. Li J, Chen M, Fan X, Zhou H. Recent advances in bioprinting techniques: approaches, applications and future prospects. Journal of translational medicine. 2016;14(1):1-15. https://doi.org/10.1186/s12967-016-1028-0
  7. Groll J, Burdick JA, Cho D-W, Derby B, Gelinsky M, Heilshorn SC, et al. A definition of bioinks and their distinction from biomaterial inks. Biofabrication. 2018;11(1):013001. https://doi.org/10.1088/1758-5090/aaec52
  8. Gungor-Ozkerim PS, Inci I, Zhang YS, Khademhosseini A, Dokmeci MR. Bioinks for 3D bioprinting: an overview. Biomaterials science. 2018;6(5):915-46. https://doi.org/10.1039/C7BM00765E
  9. Ozbolat IT, Hospodiuk M. Current advances and future perspectives in extrusion-based bioprinting. Biomaterials. 2016;76:321-43. https://doi.org/10.1016/j.biomaterials.2015.10.076
  10. Ozbolat IT, Peng W, Ozbolat V. Application areas of 3D bioprinting. Drug discovery today. 2016;21(8):1257-71. https://doi.org/10.1016/j.drudis.2016.04.006
  11. Augustine R. Skin bioprinting: a novel approach for creating artificial skin from synthetic and natural building blocks. Progress in biomaterials. 2018;7(2):77-92. https://doi.org/10.1007/s40204-018-0087-0
  12. He P, Zhao J, Zhang J, Li B, Gou Z, Gou M, et al. Bioprinting of skin constructs for wound healing. Burns & trauma. 2018;6. https://doi.org/10.1186/s41038-017-0104-x
  13. Xu J, Zheng S, Hu X, Li L, Li W, Parungao R, et al. Advances in the research of bioinks based on natural collagen, polysaccharide and their derivatives for skin 3D bioprinting. Polymers. 2020;12(6):1237. https://doi.org/10.3390/polym12061237
  14. Liu F, Liu C, Chen Q, Ao Q, Tian X, Fan J, et al. Progress in organ 3D bioprinting. International Journal of Bioprinting. 2018;4(1). 10.18063/IJB.v4i1.128
  15. Bose S, Vahabzadeh S, Bandyopadhyay A. Bone tissue engineering using 3D printing. Materials today. 2013;16(12):496-504. https://doi.org/10.1016/j.mattod.2013.11.017
  16. Wang X, Ao Q, Tian X, Fan J, Wei Y, Hou W, et al. 3D bioprinting technologies for hard tissue and organ engineering. Materials. 2016;9(10):802. https://doi.org/10.3390/ma9100802.
  17. Sopyan I, Mel M, Ramesh S, Khalid K. Porous hydroxyapatite for artificial bone applications. Science and Technology of Advanced Materials. 2007;8(1-2):116. https://doi.org/10.1016/j.stam.2006.11.017
  18. Freeman FE, Burdis R, Kelly DJ. Printing New Bones: From Print-and-Implant Devices to Bioprinted Bone Organ Precursors. Trends in Molecular Medicine. 2021. https://doi.org/10.1016/j.molmed.2021.05.001
  19. Leucht A, Volz A-C, Rogal J, Borchers K, Kluger P. Advanced gelatin-based vascularization bioinks for extrusion-based bioprinting of vascularized bone equivalents. Scientific reports. 2020;10(1):1-15. https://doi.org/10.1038/s41598-020-62166-w
  20. Gao G, Huang Y, Schilling AF, Hubbell K, Cui X. Organ bioprinting: are we there yet? Advanced healthcare materials. 2018;7(1):1701018. https://doi.org/10.1002/adhm.201701018
  21. You F, Eames BF, Chen X. Application of extrusion-based hydrogel bioprinting for cartilage tissue engineering. International journal of molecular sciences. 2017;18(7):1597. https://doi.org/10.3390/ijms18071597
  22. Roseti L, Cavallo C, Desando G, Parisi V, Petretta M, Bartolotti I, et al. Three-dimensional bioprinting of cartilage by the use of stem cells: a strategy to improve regeneration. Materials. 2018;11(9):1749. https://doi.org/10.3390/ma11091749
  23. Daly AC, Critchley SE, Rencsok EM, Kelly DJ. A comparison of different bioinks for 3D bioprinting of fibrocartilage and hyaline cartilage. Biofabrication. 2016;8(4):045002. https://doi.org/10.1088/1758-5090/8/4/045002
  24. World Health Organization. Cardiovascular diseases (CVDs) [Internet]. World Health Organization; 2021 [updated 2021 Jun 11; cited 2021 July 11]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
  25. Liaw NY, Zimmermann W-H. Mechanical stimulation in the engineering of heart muscle. Advanced drug delivery reviews. 2016;96:156-60. https://doi.org/10.1016/j.addr.2015.09.001
  26. Radisic M, Park H, Shing H, Consi T, Schoen FJ, Langer R, et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proceedings of the National Academy of Sciences. 2004;101(52):18129-34. https://doi.org/10.1073/pnas.0407817101
  27. Duan B, Kapetanovic E, Hockaday LA, Butcher JT. Three-dimensional printed trileaflet valve conduits using biological hydrogels and human valve interstitial cells. Acta biomaterialia. 2014;10(5):1836-46. https://doi.org/10.1016/j.actbio.2013.12.005
  28. Paşca AM, Sloan SA, Clarke LE, Tian Y, Makinson CD, Huber N, et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nature methods. 2015;12(7):671-8. https://doi.org/10.1038/nmeth.3415
  29. Gu Q, Tomaskovic‐Crook E, Lozano R, Chen Y, Kapsa RM, Zhou Q, et al. Functional 3D neural mini‐tissues from printed gel‐based bioink and human neural stem cells. Advanced healthcare materials. 2016;5(12):1429-38. https://doi.org/10.1002/adhm.201600095
  30. Wang S, Guan S, Li W, Ge D, Xu J, Sun C, et al. 3D culture of neural stem cells within conductive PEDOT layer-assembled chitosan/gelatin scaffolds for neural tissue engineering. Materials Science and Engineering: C. 2018;93:890-901. https://doi.org/10.1016/j.msec.2018.08.054
  31. Galliger Z, Vogt CD, Panoskaltsis-Mortari A. 3D bioprinting for lungs and hollow organs. Translational Research. 2019;211:19-34. https://doi.org/10.1016/j.trsl.2019.05.001
  32. Horváth L, Umehara Y, Jud C, Blank F, Petri-Fink A, Rothen-Rutishauser B. Engineering an in vitro air-blood barrier by 3D bioprinting. Scientific reports. 2015;5(1):1-8. https://doi.org/10.1038/srep07974
  33. Mahfouzi SH, Tali SHS, Amoabediny G. 3D bioprinting for lung and tracheal tissue engineering: Criteria, advances, challenges, and future directions. Bioprinting. 2021;21:e00124. https://doi.org/10.1016/j.bprint.2020.e00124
  34. Hoch E, Tovar GE, Borchers K. Bioprinting of artificial blood vessels: current approaches towards a demanding goal. European Journal of Cardio-Thoracic Surgery. 2014;46(5):767-78 https://doi.org/10.1093/ejcts/ezu242
  35. Aljohani W, Ullah MW, Zhang X, Yang G. Bioprinting and its applications in tissue engineering and regenerative medicine. International journal of biological macromolecules. 2018;107:261-75. https://doi.org/10.1016/j.ijbiomac.2017.08.171
  36. Mota C, Camarero-Espinosa S, Baker MB, Wieringa P, Moroni L. Bioprinting: from tissue and organ development to in vitro models. Chemical reviews. 2020;120(19):10547-607. https://doi.org/10.1021/acs.chemrev.9b00789
  37. Chang TMS. ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology. Artificial cells, nanomedicine, and biotechnology. 2019;47(1):997-1013. https://doi.org/10.1080/21691401.2019.1577885
  38. Xia Z, Jin S, Ye K. Tissue and organ 3D bioprinting. SLAS TECHNOLOGY: Translating Life Sciences Innovation. 2018;23(4):301-14. https://doi.org/10.1177/2472630318760515
  39. Turunen S, Kaisto S, Skovorodkin I, Mironov V, Kalpio T, Vainio S, et al. 3D bioprinting of the kidney—hype or hope? 2018. https://urn.fi/URN:NBN:fi:tty-201901211125
  40. Peng W, Unutmaz D, Ozbolat IT. Bioprinting towards physiologically relevant tissue models for pharmaceutics. Trends in biotechnology. 2016;34(9):722-32. https://doi.org/10.1016/j.tibtech.2016.05.013
  41. Diehl AM. Liver regeneration. Front Biosci. 2002;7:e301-14. Epub 2002/06/28. doi: 10.2741/a925. PubMed PMID: 12086922. https://pubmed.ncbi.nlm.nih.gov/12086922/
  42. Lee K-H, Lee J, Lee S-H. 3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip. Lab on a Chip. 2015;15(19):3822-37. https://doi.org/10.1039/C5LC00611B
  43. Kryou C, Leva V, Chatzipetrou M, Zergioti I. Bioprinting for liver transplantation. Bioengineering. 2019;6(4):95. https://doi.org/10.3390/bioengineering6040095
  44. World Health Organization. Diabetes [Internet]. World Health Organization; 2021 [updated 2021 Nov 10; cited 2021 July 11]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
  45. Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, Standl E, Beulens JW. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. European journal of preventive cardiology. 2019 Dec;26(2_suppl):25-32. https://doi.org/10.1177/2047487319878371
  46. Kim J, Kang K, Drogemuller CJ, Wallace GG, Coates PT. Bioprinting an artificial pancreas for type 1 diabetes. Current diabetes reports. 2019;19(8):1-10. https://doi.org/10.1007/s11892-019-1166-x
  47. Duin S, Schütz K, Ahlfeld T, Lehmann S, Lode A, Ludwig B, et al. 3D Bioprinting of functional islets of langerhans in an alginate/methylcellulose hydrogel blend. Advanced healthcare materials. 2019;8(7):1801631. https://doi.org/10.1002/adhm.201801631
  48. Zhang B, Xue Q, Li J, Ma L, Yao Y, Ye H, et al. 3D bioprinting for artificial cornea: Challenges and perspectives. Medical engineering & physics. 2019;71:68-78. https://doi.org/10.1016/j.medengphy.2019.05.002
  49. Sorkio A, Koch L, Koivusalo L, Deiwick A, Miettinen S, Chichkov B, et al. Human stem cell based corneal tissue mimicking structures using laser-assisted 3D bioprinting and functional bioinks. Biomaterials. 2018;171:57-71. https://doi.org/10.1016/j.biomaterials.2018.04.034
  50. Memic A, Navaei A, Mirani B, Cordova JAV, Aldhahri M, Dolatshahi-Pirouz A, et al. Bioprinting technologies for disease modeling. Biotechnology letters. 2017;39(9):1279-90. https://doi.org/10.1007/s10529-017-2360-z
  51. Sánchez-Salazar MG, Álvarez MM, Trujillo-de Santiago G. Advances in 3D bioprinting for the biofabrication of tumor models. Bioprinting. 2021;21:e00120. https://doi.org/10.1016/j.bprint.2020.e00120
  52. Mao S, Pang Y, Liu T, Shao Y, He J, Yang H, et al. Bioprinting of in vitro tumor models for personalized cancer treatment: a review. Biofabrication. 2020;12(4):042001. https://doi.org/10.1088/1758-5090/ab97c0
  53. Bahlmann LC, Smith LJ, Shoichet MS. Designer biomaterials to model cancer cell invasion in vitro: predictive tools or just pretty pictures? Advanced Functional Materials. 2020;30(16):1909032. https://doi.org/10.1002/adfm.201909032
  54. Baker AE, Bahlmann LC, Tam RY, Liu JC, Ganesh AN, Mitrousis N, et al. Benchmarking to the gold standard: hyaluronan‐oxime hydrogels recapitulate xenograft models with in vitro breast cancer spheroid culture. Advanced Materials. 2019;31(36):1901166. https://doi.org/10.1002/adma.201901166
  55. Dundar M, Prakash S, Lal R, Martin DK. Future biotechnology. The EuroBiotech Journal. 2019;3(2):53-6.
  56. Wake N, Rosenkrantz AB, Huang R, Park KU, Wysock JS, Taneja SS, et al. Patient-specific 3D printed and augmented reality kidney and prostate cancer models: impact on patient education. 3D printing in medicine. 2019;5(1):1-8. https://doi.org/10.1186/s41205-019-0041-3
  57. Ashammakhi N, Ahadian S, Pountos I, Hu S-K, Tellisi N, Bandaru P, et al. In situ three-dimensional printing for reparative and regenerative therapy. Biomedical microdevices. 2019(2):42. https://doi.org/10.1007/s10544-019-0372-2
  58. Di Bella C, Duchi S, O'Connell CD, Blanchard R, Augustine C, Yue Z, et al. In situ handheld three‐dimensional bioprinting for cartilage regeneration. Journal of Tissue Engineering and Regenerative Medicine. 2018;12(3):611-21. https://doi.org/10.1002/term.2476
  59. Singh S, Choudhury D, Yu F, Mironov V, Naing MW. In situ bioprinting–bioprinting from benchside to bedside? Acta biomaterialia. 2020;101:14-25. https://doi.org/10.1016/j.actbio.2019.08.045
  60. Wang M, He J, Liu Y, Li M, Li D, Jin Z. The trend towards in vivo bioprinting. International Journal of Bioprinting. 2015;1(1). http://dx.doi.org/10.18063/IJB.2015.01.001.
  61. Ursan ID, Chiu L, Pierce A. Three-dimensional drug printing: a structured review. Journal of the American Pharmacists Association. 2013;53(2):136-44. https://doi.org/10.1331/JAPhA.2013.12217
  62. Schubert C, Van Langeveld MC, Donoso LA. Innovations in 3D printing: a 3D overview from optics to organs. British Journal of Ophthalmology. 2014;98(2):159-61. http://dx.doi.org/10.1136/bjophthalmol-2013-304446
  63. Ozbolat IT, Yu Y. Bioprinting toward organ fabrication: challenges and future trends. IEEE Transactions on Biomedical Engineering. 2013;60(3):691-9. 10.1109/TBME.2013.2243912
  64. Moldovan F. Recent trends in bioprinting. Procedia Manufacturing. 2019;32:95-101. https://doi.org/10.1016/j.promfg.2019.02.188
  65. Banks J. Adding value in additive manufacturing: researchers in the United Kingdom and Europe look to 3D printing for customization. IEEE pulse. 2013;4(6):22-6. 10.1109/MPUL.2013.2279617
  66. Hoy MB. 3D printing: making things at the library. Medical reference services quarterly. 2013;32(1):93-9. https://doi.org/10.1080/02763869.2013.749139
  67. Li PH. 3D bioprinting technologies: patents, innovation and access. Law, Innovation and Technology. 2014;6(2):282-304. https://doi.org/10.5235/17579961.6.2.282
  68. Vijayavenkataraman S, Lu W, Fuh JYH. 3D bioprinting–an ethical, legal and social aspects (ELSA) framework. Bioprinting. 2016;1:11-21. https://doi.org/10.1016/j.bprint.2016.08.001
  69. Gilbert F, O’Connell CD, Mladenovska T, Dodds S. Print me an organ? Ethical and regulatory issues emerging from 3D bioprinting in medicine. Science and engineering ethics. 2018;24(1):73-91. https://doi.org/10.1007/s11948-017-9874-6
  70. Harbaugh JT. Do you own your 3D bioprinted body?: analyzing property issues at the intersection of digital information and biology. American journal of law & medicine. 2015;41(1):167-89. https://doi.org/10.1177/0098858815591512
  71. Vermeulen N, Haddow G, Seymour T, Faulkner-Jones A, Shu W. 3D bioprint me: a socioethical view of bioprinting human organs and tissues. Journal of Medical Ethics. 2017;43(9):618-24. http://dx.doi.org/10.1136/medethics-2015-103347
  72. Tran JL. To bioprint or not to bioprint. NCJL & Tech. 2015;17:123.

Downloads

Download data is not yet available.